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Infection with group A streptococci has been implicated as 
a factor capable o f exacerbating psoriasis. In order to ex-
plore the possibility o f cross-reactivity between strepto-
coccal antigens and human skin in this phenom enon , skin 
from psoriatic patients and control subjects was reacted 
w ith 3 monoclonal antibodies against group A streptococci 
and antibody binding w as es timated by the indirect im-
munofluorecence technique. Monoclonal antibody 54.2.8 
stained the nuclei and cy toplas m of cells w ithin the epi-
dermis and epidermal appendages, as well as cells scattered 
throughout the dermis . In contras t, monoclonal antibodies 
49.8. 2 and 36.2.2 labeled the cytoplasm of epidermal cells 
and epidermal appendages but did no t react with nuclei. 
No difference in the staining patterns of control skin and 
T he role of group A streptococci in development of psoriasis is poorl y understood, but there is evidence sugges ting that psorias is in som e patients may worsen after streptococcal infection [1-5]. Although rheu-m atic fever is the m ost w idely described nonsuppur-
ative pos tstreptococcal sequela, it has been recognized fo r over 
half a century that a hos t o f o ther hypersensitivity reactions OCCLIr, 
m any of which in volve the skin [6- 9]. As ea rly as 1916, it w as 
noted that episodes of acute pharyngitis w ere followed by the 
development of guttate psoriasis [1] . Since that time, a number 
of studies have dem onstrated a statistical correlation between ep-
isodes o f psori as is and streptococcal· infection o r increased anti-
s trep tolysin 0 (ASO) titers [2-5] . Immunologic cross-reac~ivity 
am ong human tissues, including skin , and streptococcal antIgens 
has been described and may playa role in nonsuppurative post-
streptococcal phenom ena [10-13] . [n o rder to investigate the role 
of cross-reactivity between streptococci and human skin in the 
develo pment of psorias is, we have examined skin from patients 
w ith pso riasis and from norm al controls using monoclonal an-
tibodies against gro~p A streptococci. 
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uninvolved skin from patients with psoriasis was observed . 
However, skin from psoriatic lesions contained large 
amounts of cross-reactive skin component(s). Sera from 
patients with guttate psoriasis did not react differently with 
normal or psoriatic skin w hen compared with norm al sera. 
Western immunoblots of skin ex tracts demonstrated that 
monoclonal antibody 54.2.8 reacted with a family o f pro-
teins in the molecular w eight range of 60-70K. The results 
indica te that component(s) in human skin share cross-
reactive epitopes with group A streptococci. Immunologic 
cross-reactions between group A streptococci and human 
skin m ay play an important role in the exacerbation of 
certain skin disorders following streptococcal infections . ] 
Invest D ermatol 87:367- 371, 1986 
PAT IENTS AND M ETHODS 
Thirteen patients (ages 11-63 yea rs) w ith psoriasis, who were 
undergoing trea tment, were examined. T he d iagnosis of psorias is 
w as based on cl inical appearance and history. Eleven patients 
dem onstra ted guttate psori as is, and 2 had typical chronic plaque 
psorias is. Four o f the 13 patients were fem ale. Six teen control 
subj ects w ith no evidence of skin disease included 11 m ales and 
5 females (ages 20- 63 years). 
Skin Biopsy Sites for biopsy w ere anesthetized locally w ith 
1 % X ylocaine w ith epinephrine, and the specimen was obtained 
with a 3-mm biopsy punch . Control specimens w ere obtained 
from the flexor surface of the forearms , except in2 patients w here 
they w ere obtained from the knee and abdomen after excision of 
benign skin tumors. Specimens of both psoriatic lesional skiJl. and 
adjacent normal-appearing skin w ere obtained from a. ~riety of 
sites in psoriatic subjects. 
Monoclonal Antibodies and Sera Anti-streptolysin 0 titers 
were obtained for 7 of the psoriatic subj ects and the available sera 
from 3 of them was stored at - 20°C. The ASO titers ranged 
from 160-334 TODD units. Sera for immunofluorescence studies 
were diluted 1 : 10 in phos phate-buffered saline (PBS). 
M onoclonal antibodies against g roup A , M-type 5, strepto-
coccal membranes, w hich were used in this study, have been 
previously characterized [1 1]. Briefly, spleen cells from BALB /c 
BY] mice, immunized with group A streptococcal m embrane 
fragm ents, w ere fused with the X 63.AgS.6.5.4 murine m yelo m a 
cell line, and culture fluids from hybrids were screened by the 
enzym e-linked immun~orbent assay (ELISA) using w hole M-
type 5 streptococci [11]. Hybridoma cell lines were cloned in soft 
agar a minimum qf2 times. Culture fluids from 3 clones, all IgM 
isotype, 49. S.2, 54.2.S, and 36. 2.2, were used in this study . Con-
trol media contained [scove's m odified D ulbecco's m edium 
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(IMOM), 2.5% horse serum , and nonimmune mouse IgM 
(20 p,g/mJ) . 
Immunofluorescence Microscopy Skin specimens were snap-
frozen i'n isopentane and stored at - 70°C or placed in holdin g 
media containin g ammonium sul fa te, citrate bu ffe rs, n-ethyl 
maleimide, and magnesium sul fa te [14] . Those specimens 
stored in holding media were was hed in PBS prior to freezing for 
sectioning. 
Frozen sections were rehydra ted by washing in PBS 3 times 
fo r 10 min each prior to staining. T he sections were then incubated 
with primary antibody for 45 min at room temperature in a moist 
chamber. The primary antibodi es used were culture fluid s fr om 
hybridoma clones 54.2.8, 49.8.2, and 36.2.2, no rm al human sera 
diluted 1 : 10 in PBS, pso ri atic sera diluted 1: 10 in PBS, or control 
media con taining [MOM, 2. 5% horse serum , and nonimmune 
mouse Ig M (20 g/ml) (Meloy Laboratories). After incubation 
with primary antibody, the sections were washed again in PBS 
and incubated with flu orescein-l abeled polyvalent goa t antim ouse 
immunoglobulins (Ca ppel, Malvern , Pennsyl va ni a) or polyvalent 
goat antihuman immunoglobulins (Ca lbiochem-Behring, La Jolla, 
Californi a) for 45 min at room temperature. The specimens were 
washed free of unbound antibody conju gate in PBS and exa mined 
using a Leitz Labrolux microsco pe equipped with epifluo rescence. 
Polyacrylamide Gel Electrophoresis and Western Immuno-
blots Slab gel electroph oresis was performed as described by 
Laemmli [15] . C rude extracts of epidermis were obtained by 
scraping samples of skin , obtained at autopsy and with a scalpel 
blade removin g the epidermis and upper dermis. The materi al 
obtained was suspended in PBS, vo rtexed vigorously, and then 
centrifuged at 400'g for 10 min. The supern atant was then mixed 
5 : 1 with Tris buffer containing 1 % sodium dodec)d sul fa te (SOS) 
and 1 % merca ptoethanol, and was boiled for 3 min prior to 
loading onto a 12% polyacrylamide slab gel for electrophoresis. 
Other ti ssues were extracted with 4% T riton X-1 00 and were 
treated with SOS and mercaptoethanol prior to electroph ores is 
as previously described [11] . 
c 
T H E JO URN AL O F INVESTIG ATIVE DERM AT O LOGY 
After electroph oresis, the separated proteins in the poly-
acrylamide gel were e1ectroblo tted onto nitrocellulose membrane 
filters and stained with monoclonal antibody 54.2.8 as has been 
previously described [11]. Proteins th at reacted w ith the mono-
clonal antibody were revea led after in cubati on w ith peroxidase-
labeled goa t antimouse immunoglobulin and the addition of the 
peroxidase substrate I-hO~ and indica to r 4-chl o ro-1-napthol. . 
RESULTS 
Frozen sections of skin were reacted w ith each of the monoclonal 
antibodies and antibody binding es timated by indi rec t immu-
noflu orescence. Each antibod y reacted w ith the skin in a distinct 
pattern of immunoflu o rescence. Monoclonal antibody 54.2.8 re-
acted with h oth dermis and epidermis o f normal skin (Fig I a) . 
T he nuclei and cy toplas m of epiderm al cells from basal layer to 
the granul ar layer (Fig 1b) , and cells w ithin sebaceo us glands, 
swea t glands (Fig l e), and hair fo llicles stained with a similar 
pattern when reacted with monoclonal antibody 54.2.8. Cells in 
the dermis were labeled w hich appea red to be in both a perivas-
cul ar and rando ml y scattered distribution. 
Monoclonal antibody 54.2. 8 reacted in a similar pattern with 
skin fro m psori atic patients. Pso ri atic lesional skin dem onstrated 
acanthosis, hyperkeratosis, and an inflammatory infiltrate no t 
present in norm al skin (Fig ld). Inflamm atory cells in psoriatic 
lesional skin were brightl y labeled in the upper dermi s. Unin-
volved normal skin fro m pso ria tic patients exhibited a fluores-
cence pattern indistin guishable fro m normal control skin (Fig 1 e). 
Monoclonal antibody 49.8. 2 demonstrated marked binding to 
skin specimens, but the binding pattern Qf 49.8.2 was different 
from monoclonal antibody 54.2.8. Monoclonal antibody 49.8.2 
reacted w ith cytoplasmic components of virtuall y all the cells 
within the epidermis (Fig 2a). Accentuation o f basal cell staining 
was seen in some, but not all specimens o f both norm al skin and 
nonlesional psoriatic skin (data not shown) . E pidermal appen-
dages and erector pili muscle also reacted with monoclonal an-
tibody 49.8.2 (data not shown) . Skin specim ens o f psoriatic le-
sional skin (Fig 2b), nonles ional skin (Fig 2e), and normal control 
Figure 1. Immunofluo rescence stain-
in g of skin sections when reacted w ith 
monoclonal antibody 54.2.8. n, N or-
mal hum an skin : the epidermis was 
brightly labeled , and the dermis also 
stained aro und w hat appea r to be neu-
rovascular bundles ( X 100). b, N ormal 
epidermis: individual nuclei o f kerat-
inocytes w ere discretely labeled 
( X 400) . c, N ormal dermis: multiple 
coils o f a sweat g land (SC) as well 
as a solitary hair (H F) w ere stained 
( x 100). d, Lesional psoriati c skin; the 
acantho tic epidermis and the accom-
panying dermal inflammatory cells w ere 
stained ( x 250). e, N onles ional pso-
riati c skin : the pattern of labeling can-
not be distinguished fro m normal skin 
( x 100). 
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Figure 2. Immunofluorescence staining of skin sections when reacted with monoclonal antibody 49.8.2. n, Normal skin:bright cytoplasmic flu orescence 
of keratinocytcs and sca ttered dermal sta ining was obscrved (x 100). b, Psoriatic les ion31 skin : the ce lls of thc acanthotIC epidermiS as well as cl ustered 
cells in the dermal papillae were labelcd (x 250). c, Nonlesional psoriatic skin: the staining pattern was not distinguishable from the pattern of normal 
skin (X 100). 
skin (Fig 2a) demonstrated no sig nifi cant differences in binding 
pattern s of monoclo na l 49.8.2, except for the typi cal histo logic 
changes seen in pso riatic sk in (aca nthosis, hyperkeratoSIs, and 
inflammatory infiltrate). There was no nuclea r flu orescence seen 
w hen monoclonal antibody 49.8.2 was reacted w ith sk in sectio ns. 
M onoclonal antibody 36.2.2 demonstrated a pattern of flu o-
rescence similar to that of m onoclonal antibody 49.8.2, but of 
lesser intensity (Fig 30). In normal and psoriati c no nl esiona l and 
lesio nal sk in the cytoplasm of cells in the epidermis, epiderm al 
appendages, erector pili muscle, and inflamm atory cell s was la-
beled, but no nucl ea r fluores cence was o bserved (Fig 3b,c) . N o nle-
sional skin fro m pso ri atic patients sta ined in a pattern indi stin-
g uish able from no rm al control ski n . In all experim ents norma l 
skin contro ls were reacted with lM DM conta ining 2.5% horse 
serum and 20 JLg/ml nonimmune mouse IgM (Figs 3d, 4) . N o 
signifi cant reaction was observed with contro l mcdia containing 
nonimmune m o usc Ig M . 
Sera from 3 patients w ith psoriasis were exa mined for the pres-
ence of binding to normal, no nlesio nal psoriatic, and in volved 
psoriatic skin . Although fa int cytoplasmi c flu orescence was noted, 
these sera dem o nstrated binding no g reater ' th an binding of no r-
mal pooled human sera (da ta not shown). 
In order to determine which compo nents of human sk in reacted 
with monoclonal antibody 54.2.8, human sk in extracts were sol-
ubilized in SDS and sepa rated by electropho resis. Western im-
munoblo ts of the separated skin pro teins were reacted w ith mono-
clonal antibody 54.2.8 (Fig 5). Proteins in the molecular weight 
range of 60-70K reacted with 54.2.8. I-!cart extrac ts were com-
pared w ith th ose from sk in. Majo r bands near 200K were ob-
served with hea rt extracts as have been previously described [11 ,12]. 
a b c 
Control immunoblots of nonimmune mouse IgM (20 JLg/ ml) did 
not react w ith proteins in the extra cts of hea rt or skin (data not 
shown) . 
DISC U SSIO N 
T he aSSOCiatio n between psorias is and antecedent streptococcal 
infectio n has been o bserved for many years (1-5]. Multiple case 
reports describe the development of guttate pso riasis o r exacer-
bation of ch ronic plaque psorias is durin g convalescence from acute 
streptococca l pharyngitis r1-5]. Numerous in ves ti gators have o b-
served cross-reactivity between antibod ies against s treptococcci 
and human or an imal tissue, including skin [1 0-13, 16]. Strep-
tococca l ant igens that have demonstrated cross-reactivity with 
mammalian tissues have been M protein [1 7], m embrane com-
ponents [11 ,12], and group A polysaccharide [1 4,18]. Because 
rheumatic fever was th e ea rlies t recogni zed seq uela of strepto-
coccal infectio n , the rheumatic disease of the heart has been the 
most thoroughly studied. C ross-reactivity between group A 
streptococci and myocardial sa rcolemma [11], heart and skeletal 
muscle [1 2], and heart valve glycoprotei ns [18] has been reported . 
In additio n , antibodies against streptococca l membranes reacted 
with ca ud ate nuclei of brain [1 9] and with fibroblasts [20], thy-
mus, and skin [16] . 
T he reaction of streptococca l-induced antibodies w ith skin is 
of partiCLllar interest with rcgard to the el icitatio n of cu ta neous 
crupti ons fo llowing streptococca l infectio n. Antibodies from rab-
bits immunized with streptococca l w all po lysaccharide have been 
shown to label th e cytoplas m of basa l cell s of skin from humans, 
mi ce, rats, rabbits, and guinea pigs [1 6]. T hese same antibodies 
reacted w ith other ep ithelial tiss ues, including epithelial cell s 
Figure 3. Immullofluorcsccnce staining of ski n sec-
tions whclI reacted with monoclonal antibody 36.2.2. 
n, Norm al skin ( x 64). b, Psoriatic lcsional skin : kc-
ratinocytcs arc stained (x '64). c, Nonlcsional psoriatic 
skin ( X 100). 
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Figure 4. Immunofluorescence staining of norm al human skin when 
reacted with 2.5% horse serum and 20 p.g/ ml control mouse IgM 
( x 64). 
of the thymus [16]. Antibodies prepared in rabbits against 
human epidermi s reacted with selected strains of g roup A strep-
tococci [21] . 
Recentl y, murine m onoclonal antibodies w ere produced that 
cross-reacted w ith both group A streptococci and hea rt [11]. Some 
of these m onoclonal antibodies were discovered to cross-react 
with muscle myosin [1 2]. These monoclonal antibodies were studied 
for their reactivity w ith skin , both no rm al and psoriati c, and at 
leas t 2 different patterns of flu o rescent labeling of human skin by 
the diffe rent m onoclonal antibodies were observed. M onoclonal 
antibody 54.2.8 , o rig inall y discovered to react w ith ca rdiac and 
skel etal muscle m yosin [11,1 2], labeled the nuclei o f epiderm al 
kera tinocytes and" reac ted w ith numerous cells in the dermis. It 
clea rl y labeled cells around blood vessels, sugges tin g an affinit y 
fo r either endo th elial cell s o r sm ooth muscle cells, and also reacted 
w ith inflammato ry cells and fib roblas ts. In contras t, m onoclonal 
antibod y 49.8.2 reacted with the cy toplas m o f epidermal cells, 
sparin g the nuclei, and ' its reaction w ith elem ents of the dermis 
w as much less pronoun ced than monoclonal antibody 54. 2.8. 
Monoclonal an tibod y 49.8.2 did no t react with m yosin in pre-
vious studi es , and the hos t p ro tein to w hi ch it reacts relll.ain s 
unidentifi ed [1 3]. H owever, m onoclonal antibody 36.2.2, which 
reacted strongly w ith skeletal Illuscle m yosin [1 3], reacted 'w ith 
the epidermis in a similar pattern to 49 .8.2 but w ith less intensity. 
Studies are in progress to furth er identify shared epitopes 'and 
cross-reacti ve an tigens of the host tissue and streptococci. Western 
immunoblo ts of SDS-extrac ted skin antigens demonstrated pro-
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Figure 5. Western immunoblot of extracts of human heart (H) and skin 
(S) when reacted with monoclonal antibody 54.2.8. The proteins in the 
skin that reacted with 54. 2.8 are in the molecular weight range of 60-70K. 
TH E JO U RNAL OF INVESTIGATIV E D ERMATOLOGY 
reactive w ith the m onoclonal antibodies. O ur most recent studies 
have confirmed that monoclonal antibody 36. 2. 2 reacts stron gly 
with keratin and m yosin w hile 54.2.8 reacts stron gly with m yosin 
and DNA (unpublished data). Stru ctural similarity between strep-
tococcal M pro tein , keratin , and m yosin has been sugges ted [22]. 
Sera fro m patients w ith guttate psorias is and previous strep-
tococcal infection failed to dem onstrate increased or unique la-
beling of skin over that o f no rm al contro l sera w hen examined 
by inimunofluorescence. In addi tion , psoriatic and normal indi-
viduals did no t dem onstrate qualitative di fferences in reactivity 
w ith the monoclonal antibodies except fo r the g reater overall 
flu orescence seen in acanth o tic epidermis o f lesional skin . These 
results suggest that m ore of the cross-reactive epitopes m ay be 
present in the lesional skin . 
The pathologic signifi cance of cross-reactivity betw een strep-
tococci and human skin is no t full y understood . The m echanism 
by w hich immunologic injury mi ght be m edi ated cann ot be dis-
cerned from this wo rk , but the absence of cross- reacting anti-
bodies in the serum of pati ents w ith guttate psorias is does no t 
rule out a ro le fo r anti body-mediated disease. Antibody titers 
m ay rise earl y in th eir co urse leadin g to initiati on of skin lesion s 
and m ay have fall en prio r to our exa minati on. It is also possible 
that antibody m ay be present but bound to tiss ues. Previou s 
studies o f lymphoid cell s in patients w ith pso rias is have dem-
onstrated th e presence of antinuclea r antibodies w hi ch can b e 
eluted from lymphocytes and polymorphonuclear leukocytes [23]. 
The binding pattern o f these antibodies w as antinuclear , and re-
sembled the pattern we observed with m onoclonal antibody 54.2.8. 
Another possibility is th at the process is antibody independent 
and that the primary effector system m ediating immunologic 
injury is cellul ar. Sensiti zed T cells may recognize the cross-
reacting epitopes and attack tissues express ing them. C ells that 
might be affected include keratinocytes , endo thelial cells, o r fi-
broblas ts, and clinical lesions might develop as a result o f a gen-
eralized Koebner phenom enon. T he presence of cross-reacting 
sites in th e skin o f bo th pso riatic patients and no rmal controls 
does no t suppo rt the hypothesis that unique anti genic sites are 
present in pso riatic patients which are responsible for their in-
dividual reactivity . Individual host facto rs regulatin g the im-
munologic res ponse directed against "self' after initiation b y 
streptococcal infection m ay playa central role in the enhancem ent 
or development o f psorias is foll owing group A streptococcal in-
fection. 
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